Conway Capital Management, Inc. Amyris, Inc. Transaction History

Conway Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 02, 2024	SELL	$1.7 - $4.05 $34,000 - $81,000	-20,000 Closed	0 $0
Q2 2022 Dec 02, 2024	BUY	$1.6 - $5.07 $32,000 - $101,400	20,000 New	20,000 $37 Million
Q1 2022 Dec 02, 2024	SELL	$3.92 - $5.86 $39,200 - $58,600	-10,000 Closed	0 $0
Q3 2021 Dec 02, 2024	SELL	$12.13 - $16.99 $45,487 - $63,712	-3,750 Reduced 27.27%	10,000 $137 Million
Q2 2021 Dec 02, 2024	SELL	$10.82 - $19.37 $464,989 - $832,425	-42,975 Reduced 75.76%	13,750 $225 Million
Q1 2021 Dec 02, 2024	BUY	$7.02 - $22.62 $245,699 - $791,700	35,000 Added 161.1%	56,725 $1.08 Billion
Q4 2020 Dec 02, 2024	BUY	$1.89 - $6.57 $41,060 - $142,733	21,725 New	21,725 $134 Million

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Conway Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Conway Capital Management, Inc. with notifications on news.